Research/art/teacher profile of a person
Name and surname:
doc. RNDr. Barbora Vlková, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Vlková
I.2 - Name
Barbora
I.3 - Degrees
assoc. prof. MSc. PhD.
I.4 - Year of birth
1979
I.5 - Name of the workplace
Institute of molecular biomedicine, Faculty of medicine, Comenius University in Bratislava
I.6 - Address of the workplace
Sasinkova 4, Bratislava 81108, Slovakia
I.7 - Position
researcher
I.8 - E-mail address
barbora.vlkova@imbm.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5556
I.10 - Name of the study field in which a person works at the university
molecular biology
I.11 - ORCID iD
https://orcid.org/ 0000-0003-3907-5432

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty of natural sciences, Comenius University in Bratislava
II.b - Year
2001
II.c - Study field and programme
molecular biology
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of natural sciences, Comenius University in Bratislava
II.b - Year
2003
II.c - Study field and programme
molecular biology
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of natural sciences, Comenius University in Bratislava
II.b - Year
2010
II.c - Study field and programme
molecular biology
II.4 - Associate professor
II.a - Name of the university or institution
Faculty of natural sciences, Comenius University in Bratislava
II.b - Year
2021
II.c - Study field and programme
molecular biology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Institute of molecular biomedicine Faculty of medicine, Comenius University in Bratislava 2009 - present

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
1
V.4.b - Diploma (second degree)
1
V.4.c - Dissertation (third degree)
2
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
8
V.4.b - Diploma (second degree)
5
V.4.c - Dissertation (third degree)
2
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
62
VI.1.b - Over the last six years
33
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
62
VI.1.b - Over the last six years
33
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
1238
VI.1.b - Over the last six years
998
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
1238
VI.1.b - Over the last six years
998
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
1
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Itagaki K, Kaczmarek E, Kwon WY, Chen L, Vlková B, Zhang Q, Riça I, Yaffe MB, Campbell Y, Marusich MF, Wang JM, Gong WH, Gao JL, Jung F, Douglas G, Otterbein LE, Hauser CJ. Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma. Crit Care Med. 2020 Feb;48(2):e123-e132. 

2

Lauková L, Bertolo EMJ, Zelinková M, Borbélyová V, Čonka J, Gaál Kovalčíková A, Domonkos E, Vlková B, Celec P. Early Dynamics of Plasma Dna in a Mouse Model of Sepsis. Shock. 2019 Aug;52(2):257-263. doi: 10.1097/SHK.0000000000001215. PMID: 30052582.



3

Konečná B, Lauková L, Vlková B. Immune activation by nucleic acids: A role in pregnancy complications. Scand J Immunol. 2018;87(4):e12651.


4

Čonka J, Konečná B, Lauková L, Vlková B, Celec P. Fetal DNA does not induce preeclampsia-like symptoms when delivered in late pregnancy in the mouse. Placenta. 2017;52:100‐105.


5

Tomova A, Husarova V, Lakatosova S, Bakos J, Vlkova B, Babinska K, Ostatnikova D. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav. 2015 Jan;138:179-87. doi: 10.1016/j.physbeh.2014.10.033. Epub 2014 Nov 6. PMID: 25446201.


VI.3 - The most significant research/artistic/other outputs over the last six years
1

Zhang Q, Kwon WY, Vlková B, Riça I, Kaczmarek E, Park J, Kim HI, Konecna B, Jung F, Douglas G, Otterbein LE, Hauser CJ, Itagaki K. Direct Airway Instillation of Neutrophils Overcomes Chemotactic Deficits Induced by Injury. Shock. 2021 Jul 1;56(1):119-124. doi: 10.1097/SHK.0000000000001691. PMID: 33181622; PMCID: PMC8513109.

2

Itagaki K, Kaczmarek E, Kwon WY, Chen L, Vlková B, Zhang Q, Riça I, Yaffe MB, Campbell Y, Marusich MF, Wang JM, Gong WH, Gao JL, Jung F, Douglas G, Otterbein LE, Hauser CJ. Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma. Crit Care Med. 2020 Feb;48(2):e123-e132. doi: 10.1097/CCM.0000000000004094. PMID: 31939811.


3

Kacerovsky M, Vlkova B, Musilova I, Andrys C, Pliskova L, Zemlickova H, Stranik J, Halada P, Jacobsson B, Celec P. Amniotic fluid cell-free DNA in preterm prelabor rupture of membranes. Prenat Diagn. 2018 Dec;38(13):1086-1095. doi: 10.1002/pd.5366. Epub 2018 Oct 28. PMID: 30276834.

4

Lauková L, Bertolo EMJ, Zelinková M, Borbélyová V, Čonka J, Gaál Kovalčíková A, Domonkos E, Vlková B, Celec P. Early Dynamics of Plasma Dna in a Mouse Model of Sepsis. Shock. 2019 Aug;52(2):257-263. doi: 10.1097/SHK.0000000000001215. PMID: 30052582.

5

Konečná B, Lauková L, Vlková B. Immune activation by nucleic acids: A role in pregnancy complications. Scand J Immunol. 2018 Apr;87(4):e12651. doi: 10.1111/sji.12651. PMID: 29479732.


VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

2019 Hahn, S. - Hasler, P. - Vokalova, L. - Van Breda, S.V. - Than, N.G. - Hoesli, I.M. - Lapaire, O. - Rossi, S.W.: Frontiers in Immunology, vol. 10, 2019, art. no. 659 - SCI ; SCOPUS

2

2019 Daniel, C. - Leppkes, M. - Munoz, L.E. - Schley, G. - Schett, G. - Herrmann, M.: Nature Reviews Nephrology, vol. 15, no. 9, 2019, s. 559-575 - SCI ; SCOPUS

3

2017 Fung, T.C. - Olson, C.A. - Hsiao, E.Y.: Nature Neuroscience, vol. 20, no. 2, 2017, s. 145-155 - SCI ; SCOPUS

4

2019 Machado-Aranda, D. - Delano, M.J. - Raghavendran, K.: Shock, vol. 52, no. 2, 2019, s. 143-145 - SCI ; SCOPUS

5

2018 Bianchi, D.W.: Genetics in Medicine, vol. 20, no. 9, 2018, s. 910-917 - SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

The role of NETosis in the etiopathogenesis of rheumatoid arthritis, APVV-18-0366, 2019-2023; principal investigator


Pathogenesis of rheumatoid arthritis (RA) is relatively well known and the currently available anti-inflammatory treatment is more effective than ever, but that does not mean that nothing can be improved. The etiology of RA is largely unknown, and therefore even the most modern treatment cannot be causal. One of the mechanisms that neutrophils use to fight microorganisms is the formation of extracellular traps, so called NETs in the process of NETosis. In NETosis, DNA, histones and specific enzymes are released into the extracellular space. NETs are immunogenic and can induce inflammation, which could explain the circulus vitiosus of chronic inflammation in various diseases including RA. In particular, if the presence of autoantibodies against citrullinated peptides formed during NETosis are one of the early markers of RA. Our previous research has highlighted the importance of extracellular DNA not only as a marker of tissue damage, but also as a pathogenetic factor in liver and kidney diseases or sepsis. Removal of extracellular DNA produced during NETosis or prevention of NETosis induction could be interesting therapeutic or preventive approaches in RA. The aims of this project are to: 1. Investigate and quantify NETosis markers including extracellular DNA in RA patients in an observational clinical study; 2. Describe mechanisms leading to NETosis using in vitro neutrophil functional tests and using monitoring of changes induced by biological anti-inflammatory therapy and 3. To test in animal models of RA the therapeutic or preventive effects of modulating the consequences of NETosis including the removal of extracellular DNA.

2

Deoxyribonuclease - role in the physiology and pathophysiology of pregnancy, VEGA 1/0742/21, principal investigator


Extracellular DNA (ecDNA) of fetal and maternal origin is very important for non-invasive prenatal diagnosis, but it is also recognized by the immune system and induces inflammation. Mechanisms that remove ecDNA include deoxyribonuclease (DNase). Little is known about its role in physiology and pathophysiology and even less in relation to pregnancy. In previously unpublished studies, we confirmed in 3 independent studies that ecDNA is higher in women with preeclampsia. However, the assumption that lower DNase activity may be the cause has not been confirmed. On the contrary, we surprisingly found that DNase activity is higher in preeclampsia. The aim of the project is 1) to describe the variability of DNase activity during physiological pregnancy, 2) to analyze DNase activity in relation to the amount, fragmentation and immunogenicity of ecDNA in preeclampsia, intrauterine infection and preterm birth, 3. to investigate the effect of change of DNase activity on pregnancy with pharmacological and genetic tools.

3

The role of NETosis in the pathogenesis of preeclampsia, VEGA 1/0156/17; 2017-2019; principal investigator


Preeclampsia is common pregnancy-specific disorder with increasing incidence. Abnormalities in placental development and inflammation are basic concepts in pathogenesis of preeclampsia, although etiology remains unknown. Several studies have shown elevated levels of extracellular DNA in maternal circulation during preeclampsia. This DNA is recognized by maternal immune system causing the inflammation. In our clinical study, we will examine the levels of extracellular DNA, amount of NETs, nucleosomes and activity of DNases. In animal models of preeclampsia, we will analyze the same parameters and try to reveal effects of inhibition of activity of neutrophils, inhibition of inflammatory response as well as impact of DNase on preeclampsia-like symptoms. Our aim is to confirm the hypothesis that extracellular DNA produced during activation of NETs contributes to inflammation since this DNA is oxidized in a form of nucleosomes in maternal circulation what further protects DNA from the activity of DNases.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
Harvard University Harvard University, Boston, MA, USA april - october 2018 National Scholarship Program - SAIA

IX. - Other relevant facts

Date of last update
2024-04-30